Loading insider details...
Beta
Latest Form 4 (Oct 5, 2026): Exercise/Conversion of 92,187 IMVT shares, $1.33M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Immunovant, Inc. (IMVT) | Exercise/Conversion | 92,187 | $1.33M |
| Oct 2, 2026 | Roivant Sciences Ltd. (ROIV) | Exercise/Conversion | 200,000 | $770.0K |
| Sep 2, 2026 | Roivant Sciences Ltd. (ROIV) | Exercise/Conversion | 200,000 | $770.0K |
| Aug 25, 2026 | Roivant Sciences Ltd. (ROIV) | Tax Withholding | 13,909 | $512.4K |
| Jul 30, 2026 | Roivant Sciences Ltd. (ROIV) | Exercise/Conversion | 200,000 | $770.0K |
| Jul 6, 2026 | Immunovant, Inc. (IMVT) | Exercise/Conversion | 92,188 | $1.33M |
| Jun 26, 2026 | Roivant Sciences Ltd. (ROIV) | Exercise/Conversion | 200,000 | $770.0K |
| May 22, 2026 | Roivant Sciences Ltd. (ROIV) | Tax Withholding | 34,483 | $1.12M |
| Apr 22, 2026 | Roivant Sciences Ltd. (ROIV) | Exercise/Conversion | 200,000 | $770.0K |
| Apr 9, 2026 | Immunovant, Inc. (IMVT) | Grant/Award | 232,252 | n/a |